Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials

Published:2019-08-19 Issue:1 Volume:8 Page:
ISSN:2046-4053
Container-title:Systematic Reviews
language:en
Short-container-title:Syst Rev

Author:

Wong William W. L.^ORCID,Pechivanoglou Petros,Wong Josephine,Bielecki Joanna M.,Haines Alex,Erman Aysegul,Saeed Yasmin,Phoon Arcturus,Tadrous Mina,Younis Mona,Rayad Noha Z.,Rac Valeria,Janssen Harry L. A.,Krahn Murray D.

Funder

Ontario Drug Policy Research Network

Ontario Ministry of Research, Innovation, and Science Early Researcher Award

Publisher

Springer Science and Business Media LLC

Subject

Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13643-019-1126-1.pdf

Reference100 articles.

1. Organization WH. Global hepatitis report 2017: World Health Organization; 2017.

2. Liver EAFTSOT. EASL 2017 Clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370–98.

3. Sherman M, Shafran S, Burak K, Doucette K, Wong W, Girgrah N, et al. Management of chronic hepatitis B: consensus guidelines. Can J Gastroenterol. 2007;21 Suppl C:5C–24C.

4. Ghany MG, Doo EC. Antiviral Resistance and hepatitis B therapy. Hepatology (Baltimore, Md). 2009;49(5 Suppl):S174–S84.

5. Drugs@FDA: FDA Approved Drug Products: Tenofovir Alafenamide Fumarate [Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208464 . Accessed 1 July 2018.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis;The Korean Journal of Internal Medicine;2024-07-01

2. Application of Tenofovir Alafenamide Fumarate in Patients with Chronic Hepatitis B;Advances in Clinical Medicine;2024

3. Tenofovir for children and adults with chronic hepatitis B;Cochrane Database of Systematic Reviews;2023-09-08

4. Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis;Journal of Hepatology;2023-03

5. Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario;PharmacoEconomics;2023-01-28